ライフサイエンスコーパス: envelope protein

1 volunteers vaccinated with a recombinant HIV envelope protein.

2 and compared it to currently used unblocked envelope protein.

3 ducing the same F108A mutation into the ZIKV envelope protein.

4 y of filoviruses to tolerate swapping of the envelope protein.

5 rough the action of the viral glycoprotein M envelope protein.

6 nd all of these mapped to domain A of the E2 envelope protein.

7 dity of the Abs that recognize the SIV gp120 envelope protein.

8 he mutant Gag protein biotinylated the HIV-1 Envelope protein.

9 lly important domains, each from a different envelope protein.

10 n (chi) to replace the function of the viral envelope protein.

11 s, as well as increased expression of HERV-K envelope protein.

12 immune dominant peptide, E294-302, from ZIKV envelope protein.

13 idue S368 in the lateral ridge region of the envelope protein.

14 at targets the CD4 binding site of the HIV-1 envelope protein.

15 2-domain of the spike-protein and the dengue envelope-protein.

16 ulated genes, most of which encoded putative envelope proteins.

17 tion to provide HDV with HBV surface antigen envelope proteins.

18 protein B (ApoB), ApoE, and the HCV core and envelope proteins.

19 ine based on virus-like particles expressing envelope proteins.

20 encoding putative surface and transmembrane envelope proteins.

21 infection and propagation of which depend on envelope proteins.

22 hedrovirus (AcMNPV) was shown to traffic ODV envelope proteins.

23 e interactions of M with the viral spike and envelope proteins.

24 determinant A (crdA), transport, binding and envelope proteins.

25 cross-neutralizing vaccine aimed at the HCV envelope proteins.

26 utilize mixtures of different soluble HIV-1 envelope proteins.

27 the cytoplasmic Env precursor to the virion envelope proteins.

28 ected multiple gp160 DNAs and gp140-trimeric envelope proteins.

29 aries, depending on the type of pseudotyping envelope proteins.

30 to alleviate stress caused by misfolded cell envelope proteins.

31 d conducive or adverse to the recruitment of envelope proteins.

32 or no N-linked glycosylation sites on their envelope proteins.

33 iffered from that of the unmodified membrane envelope proteins.

34 Mutations in the synaptic nuclear envelope protein 1 (SYNE1) gene have been reported to ca

35 ion of HCV with hepatic cells by binding HCV envelope protein 1 to prevent fusion.

36 r resistance-associated substitutions are in envelope protein 1, and four are in a putative fusion pe

37 Hypervariable region 1 (HVR1) within viral envelope protein 2 (E2) is involved in the usage of SR-B

38 promotes HCV particle assembly by recruiting envelope protein 2 (E2) to the virus assembly sites loca

39 We show that a paralog of Toc75, outer envelope protein 80 kD (OEP80), also uses a transit pept

40 ed that most antibodies that reacted to DENV envelope protein also reacted to ZIKV.

41 estral sequence and reconstruct a functional envelope protein (ancHTenv) that could support infection

42 riety of microscopy techniques to follow the envelope protein and a host cell PM protein during buddi

43 s) with fluorescent protein labels on the E2 envelope protein and exploited them to characterize viru

44 pe 1 CD4(+) T cell responses against the SIV envelope protein and failed to protect macaques from vir

45 Despite binding HIV envelope protein and having a high number of somatic ami

46 sential for interaction with the Lassa virus envelope protein and subsequent infection.

47 rinuclear, neuronal regions expressing viral envelope protein and the endoplasmic reticulum (ER)-asso

48 nvestigated the relative contribution of HCV envelope proteins and apolipoprotein E in the HS-binding

49 hat a single Fab molecule binds across three envelope proteins and engages three functionally importa

50 nd point out that interactions between viral envelope proteins and host cell receptors can have biolo

51 te nuclear morphology with increased nuclear envelope proteins and nuclear lamins.

52 ogens such as viruses and bacteria use their envelope proteins and their adhesin lectins to recognize

53 t protein tags on one of the viral membrane (envelope) proteins and used a variety of microscopy tech

54 ty, selective pressure exerted on the HCV E2 envelope protein, and neutralizing activity of maternal

55 rsor to the membrane protein upstream of the envelope protein, and our rVSV-ZIKV constructs showed ef

56 SIV recombinants, systemic boosting with SIV envelope protein, and subsequent repeated low-dose intra

57 required for FtsZ2-2 interaction with inner-envelope proteins, and functional complementation experi

58 Different types of viruses have different envelope proteins, and may have their shared or distinct

59 The capsid protein and envelope proteins are both arranged in organized lattice

60 Although envelope proteins are known to carry glycans, little is

61 We determined that the SGHBV envelope proteins are responsible for this property of S

62 tion is profoundly suppressed) if functional envelope proteins are supplied from HBV integrants.

63 risk associated with ZIKV vaccines using the envelope proteins as immunogens).

64 ent nanodiamonds (FNDs) coated with vaccinia envelope proteins as the model system.

65 ical forces can inhibit the function of cell envelope protein assemblies in bacteria and suggest the

66 ry-based sorting of single B cells using HIV envelope protein baits.

67 Mutation of the nuclear envelope protein barrier-to-autointegration factor 1 (Ba

68 ndent B cell epitopes and the limitations of envelope protein-based antibody screening.

69 vious reports indicate that some HIV-1 gp120 envelope proteins bind to and signal through alpha4beta7

70 ents showed that HEPC74 primarily blocks HCV envelope protein binding to CD81, while HEPC98 primarily

71 ar to MAdCAM, the V2 domain of the gp120 HIV envelope protein binds to alpha(4)beta(7) In this study,

72 II (EDIII) that is buried in the full-length envelope protein but becomes exposed in recombinant EDII

73 idue 375, which is buried in the full-length envelope protein but becomes exposed in recombinant EDII

74 gation of stress generated by misfolded cell envelope proteins but promotes expression of genes invol

75 mechanism of glycan recognition on the gp120 envelope protein by these antiviral lectins may therefor

76 Coronaviruses make use of a large envelope protein called spike (S) to engage host cell re

77 The uncleaved ectodomain of the envelope protein, called gp140, has also been made as a

78 y assays, produced by shared epitopes in the envelope proteins, can complicate the serological diagno

79 Viral envelope proteins catalyze this critical membrane fusion

80 behavior of ribosomes synthesizing the inner envelope protein CemA indicates that sorting signals for

81 Bacterial cell envelope protein (CEP) complexes mediate a range of proc

82 in (a "class I" fusogen) and West Nile virus envelope protein ("class II").

83 nd differed only by the HBV variant-specific envelope proteins coating the particles.

84 The cleaved, trimeric envelope protein complex is the only neutralizing antibo

85 ocessing and trafficking requirements of CMV envelope protein complexes and provide an example of the

86 ring which a topological switch of the large envelope protein confers infectivity.

87 g 1 (CHUP1) that encodes a chloroplast outer envelope protein constitutively induces stromules in the

88 that transcription of 2.4/2.1-kb mRNA coding envelope proteins containing large hepatitis B surface p

89 -bonding interaction network within the ZIKV envelope protein contribute to stability differences bet

90 In this study, we determined that the envelope proteins contribute to the ability of hepadnavi

91 to the third variable region (V3) of the HIV envelope protein correlate with reduced HIV infection ra

92 e spatially distinct epitopes in DIII of the envelope protein corresponding to the lateral ridge (ZV-

93 We show that the Arabidopsis nuclear envelope protein, CPR5, negatively regulates ETI and the

94 Vaccinia virus (VACV) envelope protein D8 is one of three glycosaminoglycan ad

95 dromedaries with different soluble trimeric envelope proteins derived from HIV-1 subtype C.

96 peptide derived from the stem region of ZIKV envelope protein, designated Z2, potently inhibits infec

97 as positive in two additional subjects using envelope-protein directed antibodies.

98 This envelope protein does not disclose any fusogenic activit

99 aques show that boosting with a specific HIV envelope protein does not significantly boost antibody r

100 cture epitopes near the hinge region between envelope protein domain I (EDI) and EDII.

101 mmunizations, we studied recall responses to envelope protein domain III (DIII).

102 We applied this method to the envelope protein domain III (ED3) of two medically impor

103 otifs, was constructed to display ten dengue envelope protein domain III (ED3)-targeting aptamers int

104 We have previously reported that ZIKV envelope protein domain III (EDIII) is a subunit vaccine

105 distinct vaccine components, a dengue virus Envelope protein Domain III (EDIII) subunit antigen and

106 e identified an epitope on Zika virus (ZIKV) envelope protein domain III (EDIII) that is buried in th

107 e mature and inferred-germline Ab binding to envelope protein domain III of ZIKV and other flavivirus

108 urrent VH3-23/VK1-5 neutralizing Abs to ZIKV envelope protein domain III, and identify interacting re

109 ZIKV-116 recognizes the lateral ridge of envelope protein domain III, with one critical residue v

110 uncover a full-length endogenous retrovirus envelope protein, dubbed HEMO [human endogenous MER34 (m

111 exchange-mediated folding of bacterial cell envelope proteins during periods of oxidative stress.

112 the surface of capsids and interact with the envelope proteins during virion formation.

113 fusion loop epitope (FLE), a segment of the envelope protein E that is buried at the interface of th

114 sential protein of the SARS-CoV-2 virus, the envelope protein E, forms a homopentameric cation channe

115 alizing antibodies are directed to the viral envelope protein (E) and an accepted correlate of immuni

116 osorbent assays (MAC/GAC-ELISAs) targeted at envelope protein (E) of dengue viruses (DENV), West Nile

117 Here we show that the envelope protein (E) of ZIKV is polyubiquitinated by the

118 ns in the C-terminal 204 amino acids of ZIKV envelope protein (E).

119 The West Nile Virus (WNV) envelope protein, E, promotes membrane fusion during vir

120 tensive intergenotypic sequence diversity of envelope proteins E1 and E2 of HCV and shielding of impo

121 ture-derived HCV (HCVcc) harboring authentic envelope proteins (E1/E2) has hindered neutralization in

122 Recently, the crystal structure of the viral envelope protein E2 region was resolved as well as how E

123 s influenced by the interaction of the viral envelope protein E2 with heparan sulfate (HS) proteoglyc

124 une response on conserved regions of the HCV envelope protein, E2, capable of eliciting neutralizing

125 genes encoding metabolic enzymes, cell-wall envelope proteins, efflux pumps, ion transporters, detox

126 y more MAbs neutralized DENV than reacted to envelope protein, emphasizing the significance of virion

127 d that a critical amino acid mutation in the envelope protein enhances the production of VLPs.

128 restriction mechanism that targets the HIV-1 envelope protein Env, but is overcome by Vpr and its int

129 mmune responses generated by targeting HIV-1 envelope protein (Env gp140) to either CD40 or LOX-1, tw

130 meric units of Moloney murine leukemia virus envelope protein (Env) are activated in relation to each

131 The viral envelope protein (ENV) facilitates the earliest events o

132 or targets on the gp120 component of the HIV envelope protein (Env) for broadly neutralizing antibodi

133 Syncytin genes are fusogenic envelope protein (env) genes of retroviral origin that h

134 The HIV-1 envelope protein (Env) has evolved to subvert the host i

135 The HIV-1 envelope protein (Env) is heavily glycosylated, with app

136 o of the HIV-1 structural protein Gag to the envelope protein (Env) is important for maximal virion i

137 The prefusion conformation of HIV-1 envelope protein (Env) is recognized by most broadly neu

138 The HIV-1 envelope protein (Env) is the target of neutralizing ant

139 The trimeric HIV-1 Envelope protein (Env) mediates viral-host cell fusion v

140 The envelope protein (Env) of Jaagsiekte sheep retrovirus (J

141 Here, we characterize the envelope protein (ENV) of the virus to define how it med

142 es to specific neutralizing sites on the HIV envelope protein (Env) trimer or on other pathogens.

143 face, we sought to determine whether the HIV envelope protein (Env) was genotypically and phenotypica

144 into cells is mediated by the interaction of envelope protein (Env) with specific cell surface recept

145 bodies elicited by HIV-1 coevolve with viral envelope proteins (Env) in distinctive patterns, in some

146 When these animals were boosted with envelope protein, envelope-binding antibodies were ampli

147 human immunodeficiency virus type 1 (HIV-1) envelope proteins (Envs) bind receptors on the host cell

148 HIV-1 envelope proteins (Envs) play a critical role in HIV inf

149 human immunodeficiency virus type 1 (HIV-1) envelope protein expressed by infected cells mobilize an

150 H. ducreyi, does not regulate homologues of envelope protein folding factors but does downregulate g

151 n controls nucleocapsid interaction with the envelope proteins for virus exit.

152 licon particle (VRP) or by a recombinant HIV envelope protein formulated with MF59 adjuvant, anti-env

153 The HSV particle contains at least 15 envelope proteins, four of which are required for entry

154 ontains truncated, recombinant, Dengue virus envelope protein from all four Dengue virus serotypes (D

155 Using pseudoparticles bearing HCV envelope proteins from acutely infected patients, we sho

156 patitis delta virus (HDV), requires only the envelope proteins from HBV in order to maintain persiste

157 the antiplasmin activity of miropin protects envelope proteins from plasmin-mediated degradation.

158 b-dependent cell cytotoxicity (ADCC) against envelope proteins from two clades.

159 V) was investigated for its contributions to envelope protein function and virion infectivity.

160 N-glycosylation of 2 representative envelope proteins (gC and gD) was primarily dependent up

161 apsid and a fluorescently tagged form of the envelope protein gD, we found that similar numbers of gD

162 tegument proteins VP16, VP1/2 and pUL37, and envelope protein gD.

163 Their envelope protein gene emerged de novo, leading to a majo

164 , designated nackednaviruses, which lack the envelope protein gene, but otherwise exhibit key charact

165 Testing replicons expressing representative envelope protein genes from all major HCV genotypes, we

166 ion of infectious HCV particles with primary envelope protein genes from GT 1 and GT 2-infected patie

167 meric viruses containing the premembrane and envelope protein genes of DENV-1, DENV-3, and DENV-4 gen

168 we summarize current knowledge on flavivirus envelope protein glycosylation and its impact on viral i

169 Our studies suggest that envelope protein glycosylation contributes to ZIKV patho

170 Envelope protein glycosylation has been identified as a

171 m a convalescent patient, targeting the RVFV envelope proteins Gn and Gc.

172 Previous studies demonstrated that HIV-1 envelope protein gp120 binds and signals through alpha4b

173 The HIV-1 envelope protein gp120 is both the target of neutralizin

174 Envelope protein gp120 of human immunodeficiency virus (

175 The HIV-1 envelope protein gp120 plays a major role in binding and

176 as inhibitors to prevent the binding of HIV envelope protein gp120 to DC-SIGN at nanomolar concentra

177 recognized by 2G12 as tightly as is the HIV envelope protein gp120, and they are the first construct

178 In the HIV-1 envelope protein gp120, they overlap with known antigeni

179 agents dichloroacetate and paclitaxel or HIV envelope protein gp120.

180 antibodies targeting the V1/V2 loops of the envelope protein gp120.

181 it HIV by binding to the highly glycosylated envelope protein gp120.

182 virus-based vector (ALVAC) together with an envelope protein (gp120) adjuvanted in alum.

183 As a result, binding of the HIV-1 envelope protein gp120IIIB to the CD4/CXCR4/CCR5 heteroo

184 Cs and in this form preferentially bound HIV envelope protein gp140 and whole HIV particles via the c

185 Retargeting of gammaretroviral envelope proteins has shown promising results in the iso

186 ody-based countermeasures targeting the ZIKV envelope protein have been hampered by concerns for cros

187 N-linked glycans on the HIV-1 envelope protein have been postulated to contribute to v

188 us, this is manifested as a virion where the envelope proteins have multiple structures, the envelope

189 ed deficiencies of three interacting nuclear envelope proteins have normal embryonic development and

190 des derived from the hepatitis B virus large envelope protein (HBVpreS) to specifically target the so

191 For example, in the influenza envelope protein hemagglutinin (HA), the low pH in the e

192 o account for antigenic changes in the viral envelope protein, hemagglutinin (HA).

193 The clusters of the influenza envelope protein, hemagglutinin, within the plasma membr

194 Sharing the same envelope proteins, hepatitis B virus and hepatitis delta

195 he sequence coding for the N-terminus of the envelope protein, immediately downstream of sequences en

196 spread occurrence of O-glycans in regions of envelope proteins important for virus entry, formation,

197 e number of O-glycosites distributed on most envelope proteins in all viruses and further demonstrate

198 ntroduced into soluble forms of the flexible envelope proteins in an attempt to lock them into state

199 ull-length and posttranslationally processed envelope proteins in cell culture.

200 eceptors on the cell surface or to stabilize envelope proteins in viruses.

201 conformation-dependent epitopes on the DENV envelope protein, including 1F4, a DENV1 type-specific h

202 Although the envelope protein induced secretion of IL-1beta and TNF-a

203 high selectivity for hepatocytes; the HBV L-envelope protein interacts specifically with a receptor

204 to an I-Ab-associated epitope of the F-MuLV envelope protein is dominated by clones expressing a Val

205 strates that the lateral ridge region of the envelope protein is likely an immunodominant, neutralizi

206 100 bp open reading frame (ORF) encoding the envelope proteins is fully nested within the ORF of the

207 bs) that target distinct epitopes on the HCV envelope proteins is one approach to vaccine development

208 ells that overexpress the GFP-tagged nuclear envelope protein lamin A.

209 l stiffness by overexpression of the nuclear envelope protein lamin A.

210 organization by interacting with the nuclear envelope protein Lamin B1, and heterochromatin-associate

211 alternative fates: (i) envelopment by viral envelope proteins, leading to secretion extracellularly

212 r479Phe), the gene which encodes the nuclear envelope protein LEM domain-containing protein 2 (LEMD2)

213 The influenza virus hemagglutinin (HA) envelope protein mediates virus entry by first binding t

214 ough chromosome movement mediated by nuclear envelope proteins, microtubules, and dynein.

215 We refer to these hybrid biomaterials as 'enveloped protein nanocages' (EPNs).

216 Here, we identified the nuclear envelope protein nesprin-2 as a binding partner for fasc

217 ght chain (KLC)-binding motif in the nuclear envelope proteins nesprin-1 and nesprin-2, and show that

218 uman stem cells expressed high levels of the envelope protein of an endogenized human-specific retrov

219 ral agents that target mannose sugars on the envelope protein of HIV-1.

220 the variable loop 3 (V3)-glycan patch on the envelope protein of HIV-1.

221 The envelope protein of human immunodeficiency virus-1 (HIV-

222 0 nm FNDs with rA27(aa 21-84), a recombinant envelope protein of vaccinia virus, for glycosaminoglyca

223 Taking advantage of the fact that envelope proteins of different HIV-1 strains exhibit dif

224 of these properties are associated with the envelope proteins of HIV-1, it is of interest to study t

225 ins of HIV-1, it is of interest to study the envelope proteins of Indian clade C isolates as part of

226 Hemagglutinin-esterases (HEs) are bimodular envelope proteins of orthomyxoviruses, toroviruses, and

227 Although it is known that envelope proteins of several different viruses resist IF

228 ionary relationship among the three abundant envelope proteins of WSSV, our structural studies also f

229 icular stomatitis virus (VSV) containing the envelope proteins of Zaire ebolavirus (VSV-ZEBOV) or sev

230 tion with DNA expressing the premembrane and envelope proteins of ZIKV was immunogenic in mice and no

231 as associated with the immobilization of the envelope proteins on the cell surface.

232 Alphavirus envelope proteins, organized as trimers of E2-E1 heterod

233 C) differentiation and remyelination via its envelope protein pathogenic HERV-W (pHERV-W) ENV (former

234 We show that the envelope protein PilY1 and functional type IV pili are r

235 nalysis, to date, of the changes in the cell envelope protein profile of F. succinogenes S85 in respo

236 The alphaherpesviral envelope protein pUS9 has been shown to play a role in t

237 ologies between the Zika and Dengue viruses' envelope proteins raise the possibility that cross-react

238 including NS2-mediated self-cleavage and HCV envelope protein recruitment to the virus assembly sites

239 unctional profile of Abs induced by an ALVAC/envelope protein regimen could be improved by substituti

240 ed, the precise organization of tegument and envelope proteins remains elusive.

241 lentiviruses or gammaretroviruses with their envelope proteins replaced with EBOV GP or pseudotyped w

242 ctivity results for two panels bearing viral envelope proteins representing either an intergenotype o

243 mediated by 20-nm-long homotrimers of spike envelope protein S.

244 lows users to analyze that data for each HIV Envelope protein sequence position and each antibody.

245 this R5 resistance pathway, we analyzed >500 envelope protein sequences and phenotypes from viruses o

246 of resistance to IFITM3 and that these HIV-1 envelope proteins share the same domain structure and si

247 fer the function of multiple uncharacterized envelope proteins, some of which have roles in cell divi

248 ling a concerted, fine-tuned activity of two envelope protein species, is unique among CoVs, but remi

249 ce, and Spumavirus-like particles with large envelope protein spikes and no visible electron density

250 velope dimer epitope (EDE), that bridges two envelope protein subunits that make up the 90 repeating

251 with other flaviviruses that share a similar envelope protein, such as dengue virus, West Nile virus,

252 , cis-acting loci that interact with nuclear envelope proteins, such as SUN-1, to access cytoplasmic

253 otic telomeres and interact with the nuclear envelope protein SUN1, with a possible crucial role in m

254 harbor highly conserved sites on the exposed envelope protein surface of gp120, one of which is the v

255 These vesicles carried endogenous retroviral envelope protein syncytin 1 and essentially acted as rep

256 na-associated protein LAP-1, myocyte nuclear envelope protein Syne1, BetaM itself, heme oxidases HMOX

257 es the function and area of the HIV trimeric envelope protein targeted by the monoclonal antibody 2C6

258 have revealed the key features of the HIV-1 envelope protein that are associated with viral resistan

259 e open reading frame (ORF) for the large (L) envelope protein that is essential for infectivity is pr

260 solates from recent outbreaks encode a viral envelope protein that is glycosylated, whereas many hist

261 CE HSV-1 UL20 is a nonglycosylated essential envelope protein that is highly conserved among herpesvi

262 It is a nonglycosylated envelope protein that is regulated as a gamma1 gene.

263 cription of the gene encoding LBR, a nuclear envelope protein that is required for the characteristic

264 tes have co-opted a viral gene to produce an envelope protein that prevents infection by the HERV-T v

265 r-to-autointegration factor (BAF), a nuclear envelope protein that shapes chromatin and recruits memb

266 05, as the virus from this infant yielded an Envelope protein that was successfully developed as a st

267 we identified distinct epitopes on the KoRV envelope protein that were recognized by antibodies.

268 We go on to identify cell envelope proteins that are necessary for the import of P

269 matic subunits, bind cohesin modules of cell envelope proteins, thereby anchoring the cellulosome ont

270 rhesus macaques and that delivered the same envelope protein through various modalities and with dif

271 plied cellPACK to model distributions of HIV envelope protein to test several hypotheses for consiste

272 Determining if the ability of SGHBV envelope proteins to cause the formation of virions cont

273 Manufacturing of ODV involves trafficking of envelope proteins to the inner nuclear membrane, mediate

274 art, to improper localisation of the nuclear envelope protein TPR.

275 is the first report on the mechanisms of HBV envelope protein transport among the organelles, and the

276 the 3.9- angstrom resolution structure of an envelope protein trimer from a very early transmitted fo

277 he conformational transitions that the HIV-1 envelope protein undergoes during the course of entry in

278 umans via specific cleavage of the precursor envelope protein upstream of the transmembrane domain.

279 ed as the prime, with recombinant virus plus envelope protein used as the boost.

280 polyclonal antibodies against ZIKV and DENV envelope proteins utilizing nine ZIKV and twelve DENV st

281 As one of the most abundant envelope protein, VP24 acts as a core protein interactin

282 is distinct to those of the other two major envelope proteins VP28 and VP26.

283 The envelope protein was expressed on the cell membrane of t

284 surface exposed, highly conserved peptide of Envelope protein was found to correspond to amino acid r

285 ch signaling in MEG-01 cells where the virus envelope protein was shown to interact with TAL-1, a hos

286 at targets the CD4-binding site of the HIV-1 envelope protein was used to engineer a next-generation

287 BV epitope complexes of HBV nucleocapsid and envelope proteins, we mapped their topological distribut

288 gA and secretory IgA responses against HIV-1 envelope proteins were associated with reduced risk of p

289 ovirus genus, and two unexpectedly divergent envelope proteins were identified in families that also

290 ovirions displaying distinct influenza virus envelope proteins were tested for fusion activity.

291 We report that primary HIV-1 envelope proteins-when expressed by simian-human immunod

292 ations, PLA2G1B synergized with the HIV gp41 envelope protein, which appears to be a driver that targ

293 in interacts with viral genetic material and envelope proteins while binding to the inner leaflet of

294 It encodes a membrane-bound envelope protein with fusogenic activity ex vivo, is exp

295 required to obtain high-affinity retargeted envelope proteins with narrow tropism are not understood

296 We found that the conformation of the envelope proteins with the cysteine substitutions differ

297 eresting research material for defining cell-envelope proteins without experimental cell disruption.

298 ns) that express either the full length ZIKV envelope protein (ZENV) alone or include the ZENV precur

299 nalyze binding interactions between the zika envelope protein (ZENV) and proposed host cell receptors

300 searching for the accumulation of the viral envelope protein, ZIKV ribonucleic acid (RNA), and infec